Spero Therapeutics Inc (SPRO) earnings · rev $66.8M
These earnings events as JSON? API free 100/daySpero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
This SPRO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SPRO revenue for 2025-12-31 was $66.8M. Net income was $8.6M. Revenue was up 39.2% from 2024-12-31 to 2025-12-31. SPRO currently screens at market cap $149.5M.
When the next SPRO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 39.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full SPRO research stays on the stock page; the tape stays on the quote page.
SPRO earnings FAQ
What are SPRO's latest revenue and net income?
Latest cached Spero Therapeutics Inc (SPRO) revenue for Dec 31, 2025 was $66.8M. Net income was $8.6M. Statements: https://lician.com/financials/spro
What is SPRO's latest diluted EPS?
Latest cached Spero Therapeutics Inc (SPRO) diluted EPS for Dec 31, 2025 was $0.15.
What period does the latest SPRO earnings print cover?
The latest cached Spero Therapeutics Inc (SPRO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did SPRO revenue change from the prior cached period?
Cached Spero Therapeutics Inc (SPRO) revenue was up 39.2% from $48.0M (Dec 31, 2024) to $66.8M (Dec 31, 2025). Statements: https://lician.com/financials/spro
Where are SPRO earnings listed?
Cached earnings facts for Spero Therapeutics Inc (SPRO) are listed at https://lician.com/earnings/spro. Statements: https://lician.com/financials/spro
Not investment advice.